Levofenacilmorfan
|
|
Klinički podaci
|
AHFS/Drugs.com
|
Monografija
|
Identifikatori
|
CAS broj
|
10061-32-2
|
ATC kod
|
nije dodeljen
|
PubChem[1][2]
|
5362482
|
UNII
|
7Q24AL2BR2 Y
|
Hemijski podaci
|
Formula
|
C24H27NO2
|
Mol. masa
|
361,477
|
SMILES
|
eMolekuli & PubHem
|
InChI |
InChI=1S/C24H27NO2/c26-19-10-9-18-14-22-20-8-4-5-11-24(20,21(18)15-19)12-13-25(22)16-23(27)17-6-2-1-3-7-17/h1-3,6-7,9-10,15,20,22,26H,4-5,8,11-14,16H2/t20-,22+,24+/m0/s1 Key: RCYBMSQOSGJZLO-BGWNEDDSSA-N Y |
|
Sinonimi
|
Levophenacylmorphan
|
Farmakoinformacioni podaci
|
Trudnoća
|
?
|
Pravni status
|
|
Levofenacilmorfan je organsko jedinjenje, koje sadrži 24 atoma ugljenika i ima molekulsku masu od 361,477 Da.
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.
- ↑ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.
- ↑ Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.